Fungal keratitis caused by Coniochaeta mutabilis-A case report.


Journal

Journal de mycologie medicale
ISSN: 1773-0449
Titre abrégé: J Mycol Med
Pays: France
ID NLM: 9425651

Informations de publication

Date de publication:
May 2023
Historique:
received: 18 01 2023
accepted: 29 03 2023
medline: 15 5 2023
pubmed: 4 4 2023
entrez: 3 4 2023
Statut: ppublish

Résumé

We present a rare case of recalcitrant fungal keratitis caused by Coniochaeta mutabilis, successfully managed with a course of oral, topical, intrastromal, and intracameral antifungals. A 57-year-old male on their fourth week of treatment for presumed left herpes simplex keratitis presented to clinic with severe left-sided foreign body sensation after gardening in his yard. On examination, a white corneal plaque was observed at 8 o'clock, shown to be a dense collection of fungal hyphae on confocal microscopy. Corneal cultures revealed yeast-like cells, initially identified as Kabatiella zeae by matching 100% identity with K. zeae strains CBS 767.71 and CBS 265.32 in BLASTn search using the internal transcribed spacer (ITS) sequence. Treated for over four months with topical amphotericin B and oral voriconazole without improvement, recourse to intrastromal and intracameral amphotericin B injections, coupled with the application of cyanoacrylate glue to the lesion and a bandage contact lens, led to eventual resolution. The patient subsequently underwent cataract surgery, achieving a BCVA of 20/20 in the eye. Surprisingly, upon further sequence analyses of combined ITS and large subunit ribosomal ribonucleic acid (LSU) and investigation of the K. zeae German strain CBS 767.71, the organism was revealed to be Coniochaeta mutabilis (formerly Lecythospora mutabilis). This means that the correct name for CBS 767.71 and CBS 265.32 is C. mutabilis and should be corrected in the GenBank record to avoid misleading identification in the future. This case also underscores the urgent unmet need for improved molecular diagnostic modalities in the care of corneal infections.

Identifiants

pubmed: 37012189
pii: S1156-5233(23)00028-8
doi: 10.1016/j.mycmed.2023.101384
pii:
doi:

Substances chimiques

Amphotericin B 7XU7A7DROE
Antifungal Agents 0
Voriconazole JFU09I87TR

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

101384

Informations de copyright

Copyright © 2023. Published by Elsevier Masson SAS.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None declared.

Auteurs

Jadesola Oremosu (J)

Tulane University School of Medicine, New Orleans, LA, USA; Summer Scholars Program, Department of Ophthalmology, Massachusetts Eye and Ear and Harvard Medical School, Boston, MA, USA.

Lawson Ung (L)

Department of Ophthalmology, Massachusetts Eye and Ear and Harvard Medical School, Boston, MA, USA; Infectious Disease Institute, Massachusetts Eye and Ear and Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.

James Chodosh (J)

Department of Ophthalmology and Visual Sciences, University of New Mexico School of Medicine, Albuquerque, NM, USA.

Connie Cañete-Gibas (C)

Fungus Testing Laboratory, University of Texas Health Science Center, San Antonio, TX, USA.

Nathan P Wiederhold (NP)

Fungus Testing Laboratory, University of Texas Health Science Center, San Antonio, TX, USA.

Emma C Davies (EC)

Department of Ophthalmology, Massachusetts Eye and Ear and Harvard Medical School, Boston, MA, USA. Electronic address: emma_davies@meei.harvard.edu.

Paulo J M Bispo (PJM)

Department of Ophthalmology, Massachusetts Eye and Ear and Harvard Medical School, Boston, MA, USA; Infectious Disease Institute, Massachusetts Eye and Ear and Harvard Medical School, Boston, MA, USA. Electronic address: paulo_bispo@meei.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH